Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
4.940
-0.250 (-4.82%)
At close: May 30, 2025, 4:00 PM
5.06
+0.12 (2.43%)
After-hours: May 30, 2025, 6:57 PM EDT
VIR's stock price has decreased by -51.09% in the past year and price targets may not have had time to catch up.
Vir Biotechnology Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$32.86
Upside
+565.18%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +183.40% | May 22, 2025 |
| Needham | Needham | Strong Buy Maintains $19 → $14 | Strong Buy | Maintains | $19 → $14 | +183.40% | May 12, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $28 → $21 | Strong Buy | Maintains | $28 → $21 | +325.10% | Apr 17, 2025 |
| Barclays | Barclays | Buy Maintains $26 → $31 | Buy | Maintains | $26 → $31 | +527.53% | Feb 28, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,126.72% | Feb 28, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +284.62% | Feb 27, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,126.72% | Jan 31, 2025 |
| Leerink Partners | Leerink Partners | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +304.86% | Jan 13, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,126.72% | Jan 10, 2025 |
| Morgan Stanley | Morgan Stanley | Hold → Buy Upgrades $10 → $20 | Hold → Buy | Upgrades | $10 → $20 | +304.86% | Jan 9, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $10 → $14 | Hold | Maintains | $10 → $14 | +183.40% | Jan 9, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,126.72% | Nov 20, 2024 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +284.62% | Nov 20, 2024 |
| Barclays | Barclays | Buy Maintains $28 → $26 | Buy | Maintains | $28 → $26 | +426.32% | Nov 4, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $110 | Strong Buy | Reiterates | $110 | +2,126.72% | Nov 4, 2024 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +284.62% | Nov 1, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.